KALYDECO 25 mg granules in sachet

Introduction

Package Leaflet: Information for the Patient

Kalydeco 13.4 mg granules in sachet

Kalydeco 25 mg granules in sachet

Kalydeco 50 mg granules in sachet

Kalydeco 59.5 mg granules in sachet

Kalydeco 75 mg granules in sachet

Ivacaftor

Read this package leaflet carefully before your child starts taking this medicine because it contains important information for your child.

• Keep this package leaflet, you may need to read it again.
• If you have any further questions, ask your child's doctor or pharmacist.
• This medicine has been prescribed for your child only. Do not give it to others, even if they have the same symptoms as your child, as it may harm them.
• If your child experiences any side effects, talk to your child's doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the package leaflet

1. What is Kalydeco and what is it used for
2. What you need to know before your child takes Kalydeco
3. How to take Kalydeco
4. Possible side effects
5. Storage of Kalydeco
6. Package contents and further information

1. What is Kalydeco and what is it used for

Kalydeco contains the active substance ivacaftor. Ivacaftor works by acting on the cystic fibrosis transmembrane conductance regulator (CFTR), a protein that forms a channel on the surface of cells, allowing particles such as chloride to enter and leave the cell. Due to mutations in the CFTR gene (see below), chloride movement is reduced in people with cystic fibrosis (CF). Ivacaftor helps certain abnormal CFTR proteins to open more frequently, improving the entry and exit of chloride from the cell.

Kalydeco granules are indicated:

• As monotherapy for the treatment of infants and children 4 months or older with a weight of 5 kg to less than 25 kg with cystic fibrosis (CF) and an R117H mutation in the CFTR gene or one of the following gating mutations in the CFTR gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R.
• In combination with ivacaftor/tezacaftor/elexacaftor granules in sachet for patients 2 to 6 years old who have CF, with at least one F508del mutation in the CFTR gene. If Kalydeco has been prescribed for your child to take with ivacaftor/tezacaftor/elexacaftor, read the package leaflet for ivacaftor/tezacaftor/elexacaftor. It contains important information about how to take these two medicines.

2. What you need to know before your child takes Kalydeco

Do not give Kalydeco to your child

• if your child is allergic to ivacaftor or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your child's doctor before they start taking Kalydeco.

• Tell your child's doctor if your child has or has had liver problems. The doctor may need to adjust the dose for your child.
• An increase in liver enzymes in the blood has been observed in some people taking Kalydeco (alone or in combination with ivacaftor/tezacaftor/elexacaftor). Tell your child's doctor immediately if your child has any of the following symptoms, which may indicate liver problems:
• Pain or discomfort in the upper right side of the stomach (abdomen)
• Yellowing of the skin or the whites of the eyes
• Loss of appetite
• Nausea or vomiting
• Dark urine

• The doctor will perform blood tests on your child to check how their liver is working before and during treatment, especially during the first year and especially if blood tests have shown that they have had elevated liver enzymes in the past.

• Depression (including suicidal thoughts and behaviors) has been reported in patients taking Kalydeco, mainly in combination with ivacaftor/tezacaftor/elexacaftor, usually appearing in the first three months of treatment. Tell your doctor immediately if you (or someone taking this medicine) experience any of the following symptoms: sad or changed mood, anxiety, feeling of emotional distress, or thoughts of self-harm or suicide, which may be signs of depression.

• Tell your child's doctor if your child has or has had kidney problems.

• Kalydeco is not recommended for patients who have received an organ transplant.

• In some children and adolescents, an abnormality in the lens of the eye (cataract) has been observed without any effect on vision during treatment (alone or in combination with ivacaftor/tezacaftor/elexacaftor). Your doctor may perform some eye examinations before and during treatment.

• Kalydeco should only be used if your child has one of the mutations in the CFTR gene listed in section 1 (What is Kalydeco and what is it used for).

Children

This medicine should not be given to children under 4 months, as it is not known if ivacaftor is safe and effective in these children.

This medicine should not be given in combination with ivacaftor/tezacaftor/elexacaftor to children under 2 years, as it is not known if ivacaftor is safe and effective in them.

Other medicines and Kalydeco

Tell your child's doctor or pharmacist if your child is taking, has recently taken, or might take any other medicines. Some medicines may affect the way Kalydeco works or increase the chance of side effects. In particular, tell your child's doctor if your child is taking any of the following medicines. The doctor may decide to adjust the dose or that your child needs more check-ups.

• Antifungals(used to treat fungal infections). These include fluconazole, itraconazole, ketoconazole, posaconazole, and voriconazole.
• Antibiotics(used to treat bacterial infections). These include clarithromycin, erythromycin, rifabutin, rifampicin, and telithromycin.
• Medicines for epilepsy(used to treat seizures or epilepsy). These include carbamazepine, phenobarbital, and phenytoin.
• Herbal medicines. These include St. John's Wort (Hypericum perforatum).
• Immunosuppressants(used after organ transplantation). These include cyclosporin, everolimus, sirolimus, and tacrolimus.
• Cardiac glycosides(used to treat certain heart conditions). These include digoxin.
• Anticoagulants(used to prevent blood clots). These include warfarin.
• Medicines for diabetes. These include glimepiride and glipizide.
• Medicines to lower blood pressure. These include verapamil.

Taking Kalydeco with food and drinks

Avoid giving your child foods or drinks that contain grapefruit during treatment with Kalydeco, as they may increase the risk of side effects of Kalydeco by increasing the amount of ivacaftor in your child's body.

Driving and using machines

Kalydeco may cause dizziness. If your child feels dizzy, it is recommended that they do not ride a bicycle or perform any activity that requires their full attention.

Kalydeco contains lactose and sodium.

If your child's doctor has told you that your child has an intolerance to some sugars, consult with them before your child takes this medicine.

Kalydeco contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".

3. How to take Kalydeco

Follow exactly the instructions for administration of this medicine given by your child's doctor. If you are unsure, talk to your child's doctor again.

Your child's doctor will determine the correct dose for your child. Your child should keep using all their other medicines, unless their doctor advises them to stop taking any.

Table 1 provides the recommended dosing for Kalydeco.

Table 1: Recommended dosing

Give your child the morning dose granules and the evening dose granules 12 hours apart.

If your child has liver problems, the doctor may need to reduce the dose of Kalydeco, as their liver may not remove the medicine from their body as quickly as in children with normal liver function.

• Moderate liver problems in children 6 months or older:the dose may be reduced to half of the recommended dose, i.e., one sachet once a day.
• Severe liver problems in children 6 months or older:it is not recommended, but the doctor will decide if it is suitable for your child to use this medicine, in which case the dose (as indicated in the table above) should be reduced to one sachet every two days.
• Liver problems in children between 4 months and 6 months of age:it is not recommended, but the doctor will decide if it is suitable for your child to use this medicine and what dose they should receive.

Kalydeco should be taken by mouth.

Each sachet is for single use only.

Administration of Kalydeco to your child:

• Hold the granule sachet with the cut line facing up.
• Gently shake the sachet to settle the contents.
• Open the sachet by tearing or cutting along the cut line.
• Mix the entire contents of one sachet with 5 ml of a soft food or liquid suitable for your child's age. The food or liquid should be at room temperature or cooler. Some examples of suitable soft foods or liquids include fruit or vegetable puree, yogurt, apple sauce, water, milk, breast milk, formula, or juice.
• Give the medicine to your child immediately after mixing. If this is not possible, give it within the next hour. Make sure your child takes the entire mixture immediately.
• Just before or just after administration, give your child a fatty food or snack (some examples are given below).

Fatty foods or snacks include those prepared with butter or oils or those that contain eggs. Other fatty foods include:

• Cheese, whole milk, whole milk dairy products, yogurt, breast milk, formula, chocolate
• Meat, oily fish
• Avocado, hummus (chickpea puree), soy products (tofu)
• Nuts, bars or nutritional drinks that contain fat

If your child takes more Kalydeco than they should

Your child may experience side effects, including those listed in section 4 below. If this happens, talk to your child's doctor or pharmacist. If possible, show them your child's medicine and this package leaflet.

If you forget to give Kalydeco to your child

Give the missed dose if it has been less than 6 hours since the time your child was supposed to take the dose. Otherwise, wait until it is time for the next dose. Do not give a double dose to make up for missed doses.

If you stop treatment with Kalydeco for your child

Give Kalydeco to your child for as long as their doctor recommends. Do not stop treatment unless their doctor tells you to. If you have any further questions on the use of this medicine, ask your child's doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Stomach pain (abdominal) and increased liver enzymes in the blood.

Signs of liver problems

Increased liver enzymes in the blood are common in patients with CF and have also been reported in patients taking Kalydeco alone or in combination with ivacaftor/tezacaftor/elexacaftor.

In patients taking Kalydeco in combination with ivacaftor/tezacaftor/elexacaftor,liver damage and worsening of liver functionhave been reported in people with severe liver disease. Worsening of liver function can be severe and may require a transplant.

The following may be signs of liver problems:

• Pain or discomfort in the upper right side of the stomach (abdomen).
• Yellowing of the skin or the whites of the eyes.
• Loss of appetite.
• Nausea or vomiting.
• Dark urine.

Depression

Signs of depression include a sad or changed mood, anxiety, or feeling of emotional distress.

Tell your child's doctor immediatelyif your child experiences any of these side effects.

Very common side effects(may affect more than 1 in 10 people)

• Upper respiratory tract infection (common cold), including sore throat and nasal congestion
• Headache
• Dizziness
• Diarrhea
• Stomach pain or abdominal pain
• Changes in the type of bacteria in the mucus
• Increased liver enzymes (signs of liver stress)
• Rash

Common side effects(may affect up to 1 in 10 people)

• Nasal congestion
• Ear pain, ear discomfort
• Ringing in the ears
• Redness inside the ears
• Disorder of the inner ear (feeling of dizziness or spinning)
• Problems with the sinuses (sinus congestion) Redness in the throat
• Swollen lymph nodes
• Feeling sick (nausea)
• Flu
• Low blood sugar (hypoglycemia)
• Abnormal breathing (shortness of breath or difficulty breathing)
• Wind (flatulence)
• Acne
• Itching of the skin
• Increased creatine phosphokinase (sign of muscle breakdown), observed in blood tests

Uncommon side effects(may affect up to 1 in 100 people)

• Ear blockage
• Breast inflammation
• Breast enlargement in males
• Changes or pain in the nipples
• Wheezing
• Increased blood pressure

Frequency not known(cannot be estimated from the available data)

• Liver damage (liver injury)
• Increased bilirubin (liver blood test)

Additional side effects in children and adolescents

The side effects seen in children and adolescents are similar to those seen in adults. However, increased liver enzymes in the blood are more common in young children.

Reporting of side effects

If your child experiences any side effects, talk to your child's doctor or pharmacist, even if they are not listed in this package leaflet. You can also report side effects directly through the national reporting system listed in Appendix V.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Kalydeco

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton, blister, and sachet after EXP. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Once mixed, the mixture has been shown to be stable for one hour.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Kalydeco Composition

The active ingredient is ivacaftor.

Kalydeco 13.4 mg granules in sachet:

Each sachet contains 13.4 mg of ivacaftor.

Kalydeco 25 mg granules in sachet:

Each sachet contains 25 mg of ivacaftor.

Kalydeco 50 mg granules in sachet:

Each sachet contains 50 mg of ivacaftor.

Kalydeco 59.5 mg granules in sachet:

Each sachet contains 59.5 mg of ivacaftor.

Kalydeco 75 mg granules in sachet:

Each sachet contains 75 mg of ivacaftor.

The other components are: anhydrous colloidal silica, sodium croscarmellose, hypromellose acetate succinate, lactose monohydrate, magnesium stearate, mannitol, sucralose, and sodium lauryl sulfate (E487).

See the end of section 2: Kalydeco contains lactose and sodium.

Product Appearance and Container Contents

Kalydeco 13.4 mg granules in sachet is a white or almost white granule.

Kalydeco 25 mg granules in sachet is a white to almost white granule.

Kalydeco 50 mg granules in sachet is a white to almost white granule.

Kalydeco 59.5 mg granules in sachet is a white to almost white granule.

Kalydeco 75 mg granules in sachet is a white to almost white granule.

The granules are supplied in sachets.

Kalydeco 13.4 mg granules in sachet, Kalydeco 25 mg granules in sachet, Kalydeco 50 mg granules in sachet, and Kalydeco 75 mg granules in sachet:

Container size of 56 sachets (contains 4 individual cartons with 14 sachets each).

Kalydeco 13.4 mg granules in sachet, Kalydeco 59.5 mg granules in sachet, and Kalydeco 75 mg granules in sachet:

Container size of 28 sachets (contains 4 individual cartons with 7 sachets each).

Marketing Authorization Holder

Vertex Pharmaceuticals (Ireland) Limited

Unit 49, Block 5, Northwood Court, Northwood Crescent

Dublin 9, D09 T665,

Ireland

Tel.: +353 (0)1 761 7299

Manufacturer

Almac Pharma Services (Ireland) Limited

Finnabair Industrial Estate

Dundalk

Co. Louth

A91 P9KD

Ireland

Almac Pharma Services Limited

Seagoe Industrial Estate

Craigavon

County Armagh

BT63 5UA

United Kingdom

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Date of the Last Revision of this Prospectus:

Other Sources of Information

Detailed information about this medication is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites about rare diseases and orphan medicines.